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Expression of stathmin, a microtubule-associated cytoplas-
mic protein, prominently localized in neuroproliferative
zones and neuronal migration pathways in brain, was inves-
tigated in the GnRH neuroendocrine system in vivo and the
function was analyzed using an in vitro approach. Here we
present novel data demonstrating that GnRH migrating neu-
rons in nasal regions and basal forebrain areas of mouse em-
bryos express stathmin protein. In addition, this expression
pattern is dependent on location, as GnRH neurons reaching
thehypothalamus are stathminnegative. ImmortalizedGN-11
cells, which retain many characteristics of migrating GnRH
neurons, strongly express stathmin mRNA and protein. The
role of stathmin in GnRHmigratory properties was evaluated
using GN-11 cell line. We up-regulated [stathmin-transfected
clones (STMN)] and down-regulated (STMN) the expres-
sion of stathmin in GN-11 cells, and we investigated changes
in cell morphology and motility in vitro. Cells overexpressing
stathmin assume a spindle-shapedmorphology and their pro-
liferation, as well as their motility, is higher with respect to
parental cells. Furthermore, they do not aggregate and ex-
press low levels of cadherins compared with control cells.
STMN GN-11 cells are endowed with multipolar processes,
and they show a decreasedmotility and express high levels of
cadherin protein. Our findings suggest that stathmin plays a
permissive role inGnRHcellmotility, possibly viamodulation
of cadherins expression. (Endocrinology 146: 1825–1834, 2005)
GnRH NEURONS (also known as LH-releasing hor-mone, LHRH) control the release of anterior pituitary
hormones, LH and FSH, in modulating the reproductive
functions (1). In adult vertebrates, these neuroendocrine cells
are scattered throughout the ventral forebrain and reside
predominantly in the septal-preoptic and anterior hypotha-
lamic areas (2). During embryonic development, GnRH cells
originate in the nasal placode and migrate along olfactory/
vomeronasal pathway to their final locations into the brain
(3). Although the migration of these cells, from nose to brain,
has been well documented in a variety of species (4–10),
many questions remain concerning the molecules and cues
directing GnRH cell migration.
Cell migration is a complex cellular behavior that results
from the coordinated changes in the cytoskeleton and the con-
trolled formation and dispersal of adhesion sites. Whereas the
actin cytoskeletonprovides thedriving forceat the cell front, the
microtubule (MT) network assumes a regulatory function in
coordinating rear retraction (11). Cytoskeletal rearrangements
are crucial for all these events. For example, leading edge ex-
tension depends on polymerization of actin microfilaments,
and nuclear translocation and retraction of the trailing edge
involveMT assembly and disassembly, respectively (12). Stath-
min (13) is amember of a class ofMTdestabilizing proteins that
regulate the dynamics of MT polymerization/depolymeriza-
tion and plays a critical role in the regulation of the dynamic
equilibrium of MTs during different phases of the cell cycle
(14–19) in a phosphorylation-dependentmanner (14, 16, 20).
TheMT-destabilizing activity of stathmin is turned off by cell
surface receptor kinase cascades and cycle-dependent ki-
nases (21–25).
In the adult nervous system of mammals, relevant neu-
rogenesis occurs in restricted areas, such as the olfactory
epithelium (OE), the subependymal layer, and the dentate
gyrus of the hippocampus (26, 27). Previous studies have
demonstrated a high level of stathmin expression in these
regions, supporting the idea that this protein is involved in
processes of migration and differentiation (28). Interestingly,
stathmin expression has been documented in the developing
main OE and vomeronasal organ during mouse embryonic
development as well as in populations of migrating cells
crossing the nasal mesenchyme at early stages of develop-
ment and resembling, for morphology and location, GnRH
neurons (29). Here we show that stathmin is expressed in
migrating GnRH neurons in vivo and in immortalized highly
migratory GnRH neurons (GN-11 cells). Furthermore, using
stable transfected GN-11 cells in which stathmin was up- or
down-regulated, we show that stathmin specifically modu-
lates motility properties of GN-11 cells.
Materials and Methods
All reagents were purchased from Sigma-Aldrich (St. Louis, MO)
unless otherwise specified.
Animals and tissue
The experimentswere carried out onCD-1mice (Charles River, Lecco,
Italy).
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All animal protocols were approved by the Animal Care and Use
Committee of the University of Turin.
Embryos
Timed pregnant mice [plug day, embryonic d 0 (E0)] were deeply
anesthetized and killed at specified embryonic days. Embryos were
harvested and washed in ice-cold Dulbecco’s PBS. The heads were fixed
in fresh 0.1 m (pH 7.4) PBS and 4% paraformaldehyde overnight at 4 C
and cryoprotected in sucrose solution the next day. Tissues were then
embedded in Killik frozen section medium (Bio Optic, Milan, Italy) and
frozen in liquid nitrogen-cooled isopentane. Sagittal sections were cut,
mounted on 3-aminopropyl-trietoxysilane-treated slides (Fluka, Milan,
Italy) and stored at 20 C until processing for immunohistochemistry.
Adult mice
Adult CD-1 mice postnatal d 30 (P30) were anesthetized with an ip
injection of ketamine (200 mg/kg), and perfused with 4% paraformal-
dehyde. The brains were dissected and postfixed in the same fixative
overnight at 4 C, cryoprotected in sucrose solutions and sectioned on a
cryostat. Sagittal sections were cut, mounted on 3-aminopropyl-trietox-
ysilane-treated slides (Fluka) and stored at 20 C until processing for
immunohistochemistry.
Eight-micrometer-thick sections were used for consecutive mirror
reactions, and 14-m-thick sections were used for simultaneous double-
labeling reactions.
Cell cultures
GN-11 cells (30) were grown in monolayer at 37 C in a humidified
atmosphere of 5% CO2/air, in DMEM (4500 mg glucose) containing 1
mm sodium pyruvate, 2 mm glutamine, 100 g/ml streptomycin, 100
U/ml penicillin, and supplemented with 10% fetal bovine serum (FBS,
Invitrogen Life Technologies, Inc., Grand Island, NY). The medium was
replaced at 2-d intervals. Subconfluent cells were routinely harvested by
trypsinization and seeded in 57-cm2 dishes (1  106 cells).
Plasmids construction
DNAmanipulations were carried out using standard techniques (31).
cDNA fragments containing the entire coding region of rat stathmin
were amplified by RT-PCR. The primers used (produced by Sigma-
Genosys) were designed according to the rat GenBank stathmin se-
quence (accession no. J04979): 5-TGTCTTCTGTCCAACATGGC-3 and
5-AAAACATCTCACGGTCTGGA-3 corresponding to nucleotides
154–766. The obtained fragments were purified from agarose gel using
GenElute Gel Purification Kit and cloned into the pGEM-T Vector Sys-
tem (Promega Corp., Madison, WI) following the manufacturer’s in-
structions; the target DNA amplification fragment was then sequenced.
The DNA of single colonies was obtained using GenElute PlasmidMini-
prep Kit and subcloned into the EcoRV gap of pIRESpuro2 Vector
(CLONTECH Laboratories, Palo Alto, CA). Stathmin antisense and
stathmin sense expression vectors were identified by XbaI restriction
map and denoted respectively pSTATHMIN and pSTATHMIN.
Plasmid transfection and generation of stable cell lines
pSTATHMIN, pSTATHMIN and pIRESpuro2 empty vector, as a
control, were transfected in GN-11 cells. Transfections were performed
using Lipofectamine Reagent transfection reagent (Invitrogen Life Tech-
nologies) and Optimem (Invitrogen Life Technologies) according to the
manufacturer’s instruction. Briefly, cells were seeded in 100-mm tissue
culture plates 1 d before transfection. The cell cultures, 60–80% con-
fluent, were transfected with 10 g plasmid DNA per plate for 4 h. After
48 h incubation in the appropriate growth medium, the selection of
clones was carried out for 2 wk in 10 g/ml puromycin. About thirty
different clones were collected and assayed for stathmin expression;
clones expressing high or low stathmin levels were denoted, respec-
tively, stathmin-transfected clones (STMN) or STMN cells.
Immunohistochemistry
Consecutive E12 and P30 mouse sagittal sections (8 m)were stained
for GnRH and stathmin immunoreactivity. GnRH neurons were labeled
using a rabbit polyclonal anti-GnRH antibody (LR5; a generous gift from
Dr. Benoit, Montreal, Canada) at a 1:10,000 dilution, whereas stathmin
immunoreactivity was detected using a rabbit polyclonal stathmin an-
tiserum (a generous gift from Dr. Sobel, Paris, France) at a 1:1000 di-
lution. Sections were incubated overnight at 4 C with the mentioned
antibodies diluted in 1% normal goat serum and 0.3% Triton X-100 in
PBS. Sections were then washed in PBS and incubated with antirabbit
biotinylated secondary antiserum and the Vector kit (ABC kit, Vector
Laboratories, Burlingame, CA) and processed for avidin-biotin-horse-
radish peroxidase/3-3-diaminobenzidine histochemistry. Sections
were thenwashed in PBS,mounted, and coverslipped.Negative controls
were run by omitting the primary antibody.
E12, E18, and P30 mouse sagittal sections (14 m) were double-
labeled for GnRH and stathmin immunoreactivity. Sections were incu-
bated overnight at 4 C with the mentioned antibodies diluted in 1%
normal goat serum and 0.3% Triton X-100 in PBS. The next day, sections
were washed in PBS and incubated for 1 h with anti-Rb-Cy2-conjugated
antibody (1:500, Jackson ImmunoResearch, West Grove, PA), washed in
PBS, mounted and coverslipped. For double-labeling reactions, anti-
GnRH/anti-stathmin, the AffiniPure Fab Fragment goat antirabbit IgG
(H  L) (FabBlocker, Jackson ImmunoResearch) was used according to
the manufacturer’s protocol.
Labeled sections were mounted, air-dried, and coverslipped in poly-
vinyl alcohol with the anti-fading mounting medium diazabicyclo-
octane. Fluorescent signals were detected using a FV 200 Olympus
Fluoview confocal laser scanning microscope (Olympus Corp.,
Hamburg, Germany). Only adjustment to brightness and contrast were
used in the preparation of the figures.
For immunocytochemical analysis of STMNmutants, cells were grown
on glass dishes in 10% FBS DMEM. After 24 h, cells were washed twice
with PBS, and fixed for 6 min in 100% methanol at 20 C. MT networks
were visualized using the -tubulin antibody (mouse monoclonal 1:1000,
Sigma-Aldrich) and the anti-Ms-Cy3-conjugated antibody (1:500, Jackson
ImmunoResearch). Labeled cells were observed on an IX50 inverted mi-
croscope (Olympus Corp.) equippedwith a charge-coupled device camera
CoolSNAP-Pro (Media Cybernetics, Houston, TX) and images edited with
Image Pro-Plus software (Media Cybernetics).
RT-PCR analysis
Total RNA was isolated by extraction with TRIzol (Invitrogen Life
Technologies). Single-strand cDNA was synthesized by Moloney mu-
rine leukemia virus reverse transcriptase from 1 g of total RNA primed
with 50 pmol of random hexamers (Amersham Biosciences, Piscataway,
NJ) in a 20-l reaction. Each reaction consisted of Life Technologies’
first-strand cDNAsynthesis buffer [50mmTris-HCl (pH8.3), 75mmKCl,
3 mm MgCl2], 4 mm deoxynucleotide triphosphates (Amersham Bio-
sciences), 1.8 U/l RNAsin (Amersham Biosciences) and 10 U/l Molo-
ney murine leukemia virus reverse transcriptase (Invitrogen Life Tech-
nologies). Samples were incubated at 37 C for 1 h. Negative controls:
(RT) were those in which reverse transcriptase was not added; (H2O)
were those in which sterile water instead of cDNA was added.
PCR was carried out using 5 l of cDNA and the appropriate oli-
gonucleotides (0.6–6 m) in a 30-l PCR using standard reaction buffer
[10 mm Tris-HCl (pH 8.3), 50 mm KCl, 1.5 mm MgCl2, 0.001% gelatin],
0.8 mm deoxynucleotide triphosphates (Amersham Biosciences) and
0.025 U/l of REDTaq DNA polymerase.
The following primers were used: 5-TGGCATTGTGGAAGG-
GCTCATGAC-3 and 5-ATGCCAGTGAGCTTCCCGTTCAGC-3 for
GAPDH amplification corresponding to nucleotides 544–732 (accession
no. M32599); 5-TGTCTTCTGTCCAACATGGC-3 and 5-AAAA-
CATCTCACGGTCTGGA-3 for stathmin amplification corresponding
to nucleotides 154–766 (accession no. J04979); 5-GGGACTGCAGCAG-
CAAAGC-3 and 5-GTCTGAGCATCTAGAGTTTCC-3 for c-Met am-
plification corresponding to nucleotides 296–815 (32). The amplification
of GAPDH served as a control with respect to the quality and quantity
of RNA that had been retro-transcribed into cDNA. The number of cycles
and the annealing temperature used for each primer pair were: 30 cycles
at 57 C for stathmin, 25 cycles at 62 C for c-Met, and 25 cycles at 60 C
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for GAPDH.Amplification products were separated by 1.5% agarose gel
electrophoresis and DNA bands visualized by ethidium bromide
staining.
Western blot analysis
For Western blotting analysis, GN-11 cells were solubilized in lysis
buffer [Tris-HCl (pH 7.4), 100 mmNaCl, 5 mmMgCl2, 0.5% NaDOC, 1%
Nonidet P-40, 1 mm phenylmethylsulfonyl fluoride, 2 mm orthovana-
date] on ice. Lysates were clarified by centrifugation at 14,000  g for
15min and protein content determined using a bicinchoninic acid kit for
protein determination.
Equal amounts of proteinswere boiled in Laemmli buffer [2% sodium
dodecyl sulfate, 50 mm Tris-HCl (pH 7.4), 20% -mercaptoethanol, 20%
glycerol] and subjected to 8% (cadherins and c-Met) and 15% (stathmin)
SDS-PAGE. Proteins were blotted onto Hybond-C Extra membrane
(Amersham Biosciences).
After blocking with 5% dry milk in TBST buffer [20 mm Tris, 150 mm
NaCl, 0.1% Tween 20 (pH 7.4)] filters were probed with 1:500 mono-
clonal ANTI-PAN cadherin antiserum, or 1:500 polyclonal c-Met anti-
serum (Santa Cruz Biotechnology, Inc., Santa Cruz, CA), or 1:10,000
polyclonal antistathmin antibody, or 1:1000 monoclonal -actin anti-
serum (Sigma-Aldrich) and visualized with the appropriate peroxidase-
coupled secondary antibodies using ECL detection system (Amersham
Biosciences).
Proliferation assay
Cellular proliferation was quantified with the 96-well plates tech-
nique as previously described (33, 34). Briefly, cells were plated in 200
l serum-free medium (SFM) at a density of 1000 cells/well in 96-well
plates. The following day (t  0), the medium was replaced by 100
l/well SFM with or without 50 ng/ml of human recombinant hepa-
tocyte growth factor/scatter factor (HGF/SF); for each treatment, eight
wells were used. At t  0, a 96-well plate was fixed and used as a cell
growth start point. Cell growth was subsequently calculated at 1 d (t 
24 h), 2 d (t  48 h), and 3 d (t  96 h) after the initiation of treatments.
The mediumwas removed and cells were fixed by addition of 100 l 2%
glutaraldehyde in PBS. After being shaken (200 cycles/min) for 20 min
at room temperature, plates were washed five times by submersion in
deionized water and air dried at least 24 h. Plates were then stained by
addition of 100 l/well of a solution containing 0.1% crystal violet
dissolved in freshly prepared 200 mm boric acid at pH 9.0. After being
shaken (200 cycles/min) for 20 min at room temperature, plates were
washed five times by submersion in deionized water and air dried at
least 24 h. Bound dye was solubilized by addition of 100 l/well of 10%
acetic acid and 5 min shaking at room temperature. The OD of dye
extracts was measured directly in plates using a Microplate Reader
(Bio-Rad, Hercules, CA), at the wavelength of 590 nm.
Morphological analysis of stable transfected clones
To classify and analyze different morphologies displayed by
STMN, pIRES and STMN cells, Image Pro-Plus (Media Cybernetics)
and Photoshop 7.0 software were used. Random cells were photo-
graphed using a 1 50 inverted microscope (Olympus Corp.) equipped
with a charge-coupled device camera CoolSNAP-Pro (Media Cybernet-
ics). For morphometric analysis cell body boundaries were manually
traced with processes extending from cell bodies being not taken into
account for measurements. Area, perimeter, maximum and minimum
diameter of each cell were calculated using the software Image Pro-Plus
(Media Cybernetics). Moreover, for each cell the ratio between maxi-
mum and minimum diameter of the cell body was evaluated. The mea-
sures were obtained considering only interphasic cells. All data were
collected and statistically analyzed.
Motility assay
To measure two-dimensional movement, cells were plated at low
density in culture dishes. The day after plating, cells (in DMEM-10%
FBS)were photographed every 30min for 3 h, andmotilitywas analyzed
as nuclear movement measurements. Photographs were aligned using
Reconstruct Software version 1.0.2.0 (http://synapses.bu.edu/tools)
and nuclear coordinatesweremeasured using ImageJ SoftwareNational
Institutes of Health (http://rsb.info.nih.gov/ij/). All the data were col-
lected and statistically analyzed.
Aggregation assay
Cells aggregates were prepared by the hanging drop technique (35).
Subconfluent cells were collected by trypsinization, resuspended in
complete culture medium, and 20 (5) cells were seeded in 20-l drops
on the lid of a culture dish; the lidwas then placed on a 35-mmdish filled
with 2 ml of culture medium and incubated at 37 C for 48 h.
Collagen gel was obtained as previously described (36) and 200 l were
pipetted onto the bottom of a well of a 24-well culture dish, and left to set
at room temperature. Cells aggregates were transferred over the cushion
and then overlaid with additional 200 l of collagen and covered with
culture medium; aggregates were then photographed after 1 h.
Migration assay
The Transwell migration assay was used to measure three-dimen-
sional movement. Cells (105) were seeded on the upper side of a Falcon
cell culture insert (Becton Dickinson Labware, Franklin Lakes, NJ) on a
porous polycarbonate membrane (8 m pore size, 1  105 pores/cm2)
(37); the lower chamber of the cell plate was filled with serum-free
DMEM or with serum-free DMEM containing 50 ng/ml of human re-
combinant HGF/SF. After 6 h of incubation, cells attached to the upper
side of the filterweremechanically removed,whereas cells thatmigrated
to the lower side of the filter were fixed in PBS 1% glutaraldehyde,
stainedwith toluidine blue, photographed (4mm2/sample) and counted
using Image Pro-Plus software (Media Cybernetics).
Statistical analysis
The experiments were performed in triplicates, and all counts ob-
tained from assays were analyzed, averaged, and expressed as mean 
se. SAS software (Cary, NC) was used for statistical analysis. Two-way
ANOVA was performed. Post hoc tests were used to determine where
statistically significant differences were located among the groups (Bon-
ferroni, Tukey). The level of significance, unless otherwise indicated,
was P  0.01.
Results
Stathmin is expressed by migrating GnRH neurons in situ
Stathmin expression in the GnRH system was studied in
mouse at embryonic stages E12 and E18 and in young adults
(P30) by immunohistochemistry. The analysis was per-
formed using either single-labeling immunohistochemistry
on consecutive sections (8 m apart) or double-labeling im-
munofluorescence on the same section, We showed that
GnRH neurons migrating through the nasal mesenchyme
during early stages of development express stathmin (Fig. 1).
At E12, stathmin-immunoreactivity (-ir) was detected in
cells emerging from the presumptive vomeronasal organ and
migrating in cords-like clusters toward the forebrain (Fig.
1A). To assess the relationship between GnRH and stathmin
immunolabeling, the consecutive section was stained with
anti-GnRH antiserum (Fig. 1B).
Stathmin staining pattern paralleled the GnRH neuronal
distribution in the nose at this developmental stage. GnRH-ir
overlapped partially with that for stathmin even though
stathmin expression appeared not to be restricted to GnRH
neurons. Confocal analysis of double labeling reaction on
sagittal brain sections at the same embryonic stage confirmed
the colocalization of GnRH and stathmin in the same cell
body (Fig. 1, C–E). At E18, such colocalization was still de-
tectable in GnRH neurons crossing the crybriform plate, en-
tering the developing forebrain and moving through the
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basal forebrain directed toward the hypothalamic regions
(data not shown). At this stage, within these latter locations
most GnRH neurons are stathmin negative (Fig. 1, F–H).
Accordingly, at P30, when all the GnRH neurons are fully
differentiated, no stathmin-ir can be detected in GnRH cells
in any brain regions (data not shown). These results show
that GnRH neurons express stathmin and that this expres-
sion is restricted to their migratory process being down-
regulated as the cells reach their final destinations. To further
assess the relationship between stathmin expression and the
migratory activity of GnRH neurons, we switched to an in
vitro model using the GnRH immortalized cell line, GN-11.
GN-11 cells express stathmin
To use the GN-11 cell line for functional studies, we ver-
ified that this system retained expression of stathmin com-
parable to that observed in vivo.
RT-PCR (Fig. 2A), Western blot (Fig. 2B) and immunocy-
tochemistry (not shown), demonstrated that stathmin is con-
stitutively expressed by GN-11 cell line. RT-PCRs for stath-
min transcripts yielded predicted 612-bp amplicons (Fig. 2A)
and Western blotting analysis evidenced the expression of
the 19-kDa stathmin protein (Fig. 2B) in GN-11 extracts.
Olfactory bulb extracts were used as positive controls (28)
and GAPDH amplification confirmed that equal amounts of
RNA were included in each RT-PCR.
Stathmin transfections on GN-11 neurons modify the level
of stathmin expression
The cDNAcoding for stathmin (produced byRT-PCR)was
cloned in pGEM-T vector and sequenced. The amplified
cDNA differs from the published sequence (J04979) for nu-
cleotides 210 and 526, but encodes for stathmin protein with
100%amino acidic sequence homology. The amplified cDNA
was subcloned in sense or antisense direction in pIRESpuro2
expression vector and transfected in GN-11 cells. Twenty-
FIG. 1. Stathmin andGnRH in vivo immunohistochemistry. A andB,
Immunohistochemistry for stathmin (A) and GnRH (B) performed on
consecutive sagittal sections of a E12mouse embryo. Immunoreactive
cells emerged from the developing OE and migrate in chains through
the olfactory mesenchyme toward the forebrain. Stathmin immuno-
reactivity resembles the staining pattern of GnRH. Note that the
stathmin antibody likely labels the same groups of migrating ele-
ments stained with the GnRH antiserum. fb, Forebrain; n, nose; op,
olfactory placode; t, tongue. Scale bars: *, 500 m; **, 100 m. C–E,
Double simultaneous immunohistochemical staining for stathmin (C)
and GnRH (D) at E12 in the nasal mesenchyme. A complete colocal-
ization between stathmin and GnRH is shown in panel E (merge of
C and D). Scale bars: 10 m. F–H, Double simultaneous immuno-
FIG. 2. Stathmin expression in GN-11 cell line extracts. A, Total
GN-11 mRNA was assayed by RT-PCR for stathmin, GAPDH served
as control. Predicted amplicons molecular weights were: 612 bp for
stathmin and 188 bp for GAPDH.B, GN-11 cells protein extracts were
analyzed for stathmin (19 kDa) expression. MW, Molecular weight;
OB, olfactory bulb (positive control).
histochemical staining for stathmin (F) and GnRH (G) at E18 in the
hypothalamus. As shown in panel H (merge of F and G), no colocal-
ization between stathmin and GnRH was observed in this region.
Scale bars, 10 m.
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three sense (STMN), seven antisense (STMN), and 25
empty vector (pIRES) stable clones were selected by puro-
mycin treatment and analyzed for stathmin expression at
RNA (Fig. 3A) and protein level (Fig. 3B). Transfection of the
vector containing sense stathmin cDNA allowed transcrip-
tion of stathmin mRNA, leading to an increase in stathmin
protein content (STMN) compared with control (pIRES),
whereas transfection of the vector containing antisense stath-
min cDNA, leading to production of a mRNA complemen-
tary to the endogenous mRNA, knocked down significantly
stathmin expression in these transfected cells (STMN; Fig.
3B). To exclude unspecific effects of the stathmin expression
vectors, STMN transfectants were analyzed the for transcript
levels of stathmin-unrelated genes, such as the two tyrosine-
receptors c-Met (38) and ErbB2 (39, 40) and the transcription
factor activator protein-2 (41), which are expressed in the
GN-11 parental cells. c-Met transcript levels (see Fig. 8) were
unchanged in between STMN, STMN and pIRES cells.
Unaltered levels were also observed for ErbB2 and activator
protein-2 (not shown).
Stathmin down-regulation modifies cell proliferation
The proliferation rate of stathmin transfectants was ana-
lyzed using crystal violet staining (seeMaterials andMethods).
Clones in which stathmin was down-regulated (STMN)
exhibited a proliferation activity significantly reduced com-
pared with control (pIRES; Fig. 4). Conversely, no significant
difference in the growth rate of STMN cloneswas observed
compared with control. The growth rate of control (pIRES)
was similar to that of untransfected parental GN-11 cells (not
shown).
Stathmin expression and cell morphology
Transfection of stathmin constructs induced significant
morphological changes. STMN cells displayed a spindle-
shaped body (bipolar) with the extension of two leading
processes, whereas STMN displayed a multipolar mor-
phology (Fig. 5, A and E). pIRES cells, which express an
intermediate level of stathmin compared with STMN and
STMN clones, exhibited both bipolar and multipolar mor-
phologies (Fig. 5C). Quantitativemorphological analysiswas
performed, taking into account diameter, area, andperimeter
of random cells (n 249 for STMN cells; n 228 for pIRES
cells; n  323 for STMN cells) for each clone (Fig. 6). The
mean ratio between the maximum and minimum diameter
( sem) was calculated. These values were 4.8 0.14 m for
STMN clones, 3.2  0.11 m for pIRES and 2.6  0.05 m
for STMN, confirming that a significant difference in cell
morphology existed between the three clones of transfected
cells (P  0.01).
FIG. 3. Representative stathmin expression in STMN stable trans-
fectants. A, Total mRNAs were assayed by RT-PCR for stathmin,
GAPDH served as control. Predicted amplicons molecular weights
were: 612 bp for stathmin and 188 bp for GAPDH. B, Total proteins
fromSTMN, pIRES and STMN cells were assayed byWestern blot
analysis for stathmin. -Actin served as control of the quantity of
proteins.
FIG. 4. Effect of stathmin level modulation on cell proliferation in
SFM culture condition. Lower levels of cells proliferation were found
in conditions of lower level of stathmin (STMN cells) (seeMaterials
and Methods).
FIG. 5. Morphological characteristics of STMN stable transfectants.
STMN cells displayed a spindle-shaped body with the extension of
two leading processes (A), whereas STMN were much more spread
(E). pIRES cells (C), which express an intermediate level of stathmin
compared with STMN and STMN clones, exhibited both spindle
(white arrow) and spread (black arrow) morphology. All the STMN
transfectants (B, D, and F) exhibit intact MT networks, as shown by
-tubulin-ir. Scale bars, 20 m.
Giampietro et al. • GN-11 Neurons in Vitro Endocrinology, April 2005, 146(4):1825–1834 1829
Mean cell perimeters (sem) of clones STMN, pIRES and
STMNwere 171.3 3.1m; 155.9 2.4m; 147.8 3.2m,
respectively. Statistical analysis evidenced a significant dif-
ference (P  0.05) of cell perimeters between STMN and
pIRES, STMN and pIRES, STMN and STMN clones,
respectively.Mean cell body areas (sem) of clones STMN,
pIRES, and STMNwere 798.8 41.6 m; 857.8 25.4 m;
987.2  54.7 m. Statistical analysis showed significant dif-
ference (P  0.05) between STMN and STMN clones.
To test whether the overexpression of stathmin is associ-
ated with abnormal MTs, STMN cells were immunolabeled
for -tubulin. We observed different organizations of this
cytoskeletal component between clones, which could ac-
count for STMN transfectants shape; however, the density of
MTs was not modified (Fig. 5, B, D, and F).
Stathmin level affects two-dimensional motility
Being interested in studying stathmin-mediated migra-
tion, we performed a first round of experiments to determine
whether differences of stathmin expression could modulate
motility, here defined as two-dimensionalmovement, or che-
mokinesis. The nuclear coordinates of single cells were mea-
sured every 30 min for 3 h and the mean speed of cell
movement was calculated. Our results show different che-
mokinetic responses: stathmin overexpression induced a sig-
nificant increase in motility (23.6 m/h) when compared
with the pIRES (13.5 m/h), whereas no significant differ-
ence between STMN (12.6 m/h) and pIRES cells motility
was detected.
Stathmin level modifies aggregation ability
Parental GN-11, pIRES, and STMN cells, in subconfluent
culture conditions, exhibit cell-cell adhesion, whereas
STMN cells grow exclusively as single cells.
Using the hanging drop approach (35), we showed that,
unlike pIRES and STMN, STMN cells were scattered and
spread into the collagen gel and do not aggregate at all (Fig.
7A). To further investigate a possible role for stathmin in the
impairment of cell-cell adhesion, we analyzed N-cadherin
protein expression in the different clones. As shown in Fig.
7B, we found that STMN cells expressed higher levels of
full-length N-cadherin (130 kDa) compared with pIRES cells
and a truncated (95 kDa) isoform (42), which was absent in
the STMN and pIRES clones. Concurrently with the above
observations, STMN cells express very low level of full-
length N-cadherin (130 kDa).
Stathmin level modifies three-dimensional basal and
chemotactic motility
To evaluate the ability of STMN transfectants to migrate
in a three-dimensional environment, we assayed basal mo-
tility and chemotaxis using transwell assay, a common ap-
proach for sensitive measurement of cellular response to
specific chemotropic signals (43, 44). In previous studies, we
and others (36, 45) have shown that GN-11 cells display
migratory activity. To determine whether stathmin expres-
sion was involved in GN-11 basal cell migration, transwell
assays were performed with STMN and STMN clones in
SFM. The statistical analysis of migrated cells after 6 h of
FIG. 6. Quantitative analyses of STMN stable transfectants morpho-
logical parameters. The morphometric data of every cell soma were
measured semiautomatically: cell body boundaries were manually
traced. For each cell body, spindle-shaped morphology (A) (evaluated
as ratio between maximum and minimum diameter), perimeter (B),
and area (C)were analyzed. Each value represents themean SE; n
249 STMN cells; n  228 pIRES cells; n  323 STMN cells.
Statistically significant differences of each group with one another
were observed when comparing data concerning spindle-shaped mor-
phology and perimeter (A and B). When comparing data concerning
areas, statistically significant differenceswere observed only between
STMN and STMN cells (C).
FIG. 7. A, Aggregation assays of STMN, pIRES, and STMN cells.
pIRES and STMN cells form aggregates in collagen gel (hanging
drop technique), whereas STMN cells are scattered and spread into
the collagen gel. The inset shows, at higher magnification, STMN
cells not forming aggregates. B, N-cadherin protein expression in
STMNclones. STMN cells, comparedwith pIRES, express high level
of full-length N-cadherin (130 kDa) and, in addition, the induction of
a truncated (95 kDa) isoform. Concurrently, STMN cells express
very low level of full-length N-cadherin (130 kDa).
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incubation clearly showed the different migratory activity of
pIRES, STMN and STMN clones (Fig. 8). STMN cells
exhibited a significant increase in cell migration activity
when compared with pIRES, whereas, in the same experi-
mental conditions, STMN cells showed a significant
decrease.
STMN clones were then assayed for their ability to re-
spond to the chemotactic molecule, HGF/SF. We have pre-
viously shown that GN-11 cells express the tyrosine kinase
receptor c-Met and respond to the chemotactic stimulus in-
duced by its ligand, HGF/SF (45). Cells were seeded in the
transwell and exposed to a source ofHGF/SF (50 ng/ml; Ref.
45), which was added in the bottom chamber (see Materials
and Methods). As shown in Fig. 8A, all clones responded
significantly to HGF/SF treatment, with an increase in cell
migration compared with SFM treatment. Noteworthy, the
amplitude of the response is correlated to the basal motility
of each clone. In addition, STMN cells displayed increased
cell motility both in SFM condition and in the presence of
HGF/SF when compared with pIRES cells. Concurrently,
STMN cells displayed decreased cell motility both in SFM
condition and in the presence of HGF/SF when compared
with pIRES cells. Finally, no significant differences in c-Met
expression were observed between GN-11, pIRES, STMN
and STMN cells, as detected by RT-PCR and immunoblot-
ting analyses (Fig. 8B).
Discussion
In the present paper, we show that the MT-associated
phosphoprotein stathmin is expressed in vivo in migrating
GnRH producing cells during development as well as in
vitro, in theGN-11 cells (30). In addition,we demonstrate that
the modulation of stathmin expression significantly affects
shape and motility of GN-11 cells.
During central nervous system (CNS) development and in
the adult,MTs are involved in numerous intracellular events,
such as proliferation, differentiation, and migration. In neu-
rons, MTs play specific roles in axonal outgrowth, pathfind-
ing, and synapse formation, aswell as in axonal anddendritic
transport (46). We have focused our interest on the MT-
associated protein stathmin and investigated its role as one
of the possible regulators of these events.
Stathmin phosphoprotein interferes with MT assembly
andplays an important role in the regulation ofMTdynamics
during cell cycle progression. It is also highly expressed in
early embryos (47–49), gonads (50), and in particular it has
been shown to be present in several brain areas (28, 51–54),
but its function in the CNS is not completely clear. Stathmin
has also been proposed to act as an intracellular relay for
extracellular signals (55) and many proteins, apart from tu-
bulin, have been identified as target/partners for stathmin
(56–58). A stathmin gene has also been identified in Dro-
sophila (59); like the mammalian protein,Drosophila stathmin
interferes with MT dynamics both in vitro and in vivo. Fur-
thermore, functional inactivation of the stathmin gene in
Drosophila, by RNA interference, leads to abnormal germ cell
migration in the embryo and to dramatic defects in the for-
mation of the nervous system, supporting a direct role of
stathmin in these essential biological processes.
In mammals, stathmin immunostaining in the CNS local-
izes to immature olfactory neurons as well as to migrating
cells generated from the OE, supporting the role of this
protein in neurogenesis and cell migration (29). Although
stathmin had been associated with numerous cell events, its
biological role remained elusive as inactivation of the stath-
min gene in mouse resulted in no clear deleterious pheno-
type (60). In a recent study, microinjections of stathmin an-
tisense oligonucleotides in the lateral ventricle of adult rats,
inhibited interneuronal migration from the subventricular
zone to the olfactory bulb via rostral migratory stream (61).
We now have evidence, by consecutive and simultaneous
double immunohistochemical analyses, that stathmin is ex-
pressed by GnRH neurons. This expression is specific of the
migration step and ceases as soon as GnRH neurons reach
their final hypothalamic destination. Thus, stathmin expres-
sion in GnRH neurons is temporally and spatially regulated
during mouse development. Based on the preexisting liter-
ature and on the present results, we postulated that stathmin
is involved in the control of migration properties of GnRH
neurons. To determine whether a correlation might exist
between stathmin expression level and migratory capabili-
ties of GnRH neurons, we moved to GN-11 cell line. This cell
FIG. 8. A, Three-dimensionalmigration assay. Chemotactic response
of STMN, pIRES and STMN cells, performed using the transwell
method: 105 cells were allowed to migrate for 6 h in the absence or in
the presence of 50 ng/ml HGF/SF. Each value represents the mean
SD of three experiments in triplicate. All clones respond significantly
to HGF/SF treatment, with an increase in cell migration when com-
pared with untreated conditions and the amplitude of the response is
correlated to the basal motility of each clone. STMN cells, when
comparedwith pIRES cells, display an increasedmotility both in SFM
condition and in the presence of HGF/SF. STMN cells, when com-
pared with pIRES cells, display a decreased motility both in SFM
condition and in the presence of HGF/SF. B, c-Met expression in
STMN transfectants extracts. TotalmRNAswere assayed byRT-PCR
for c-Met, GAPDH served as control. Predicted amplicons molecular
weights were: 519 bp for c-Met and 188 bp for GAPDH. Protein
extracts were analyzed for c-Met (145 kDa) expression. MW, Molec-
ular weight.
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line was derived from a tumor developed in the cribriform
plate of mouse embryos (30). GN-11 cells retain many of the
morphological and behavioral features of migrating neurons
(45, 59, 62). Therefore, this cell line provides a suitable model
to study the involvement of stathmin in the regulation of
GnRH neuronal migration.
Complete stathmin cDNA was cloned both in sense and
antisense orientation in pIRES vector and stably transfected
into GN-11 cells. Selected clones showed overexpression
(STMN) or down-regulation (STMN) of stathmin com-
paredwith control clones. As already demonstrated for K562
erythroleukemia cells (23) and for human embryonic kidney
293 cells (63), the alteration of stathmin expression in GN-11
cells induces modifications in proliferation activity, confirm-
ing a role for stathmin as mitotic regulator in this cell line.
Interestingly, beside its effect on proliferation, modifications
of stathmin expression caused also changes in GN-11 cell
morphology. High levels of stathmin expression induced the
cells to adopt the typical morphology of in vivo GnRH mi-
grating neurons (64), with elongated and spindle-shaped cell
bodies and the extension of a leading and a trailing process.
Cells expressing low levels of stathmin showed neurite-like
outgrowth and displayed a multipolar morphology. The sig-
nificance of thesemorphological observations was evaluated
and confirmed by quantitative analysis of parameters such as
area, perimeter, and shape.
Bidimensional analysis of cell motility revealed a signifi-
cant increase in the speed of STMN cells when compared
with control and STMN cells. Interestingly, STMN cells
did not establish any contact with each other, suggesting a
possible variation of the expression of cell-cell adhesionmol-
ecules. Previous studies have shown that cell adhesion mol-
ecules, including N-cadherins, are implicated in the forma-
tion of the nervous system (65). Their expression is highly
regulated during nervous systemdevelopment to control cell
migration, neurite outgrowth, fasciculation, and synapto-
genesis. It has also been demonstrated that down-regulation
of cadherin’s expression hastened the migration of newly
generated neurons produced in the subependymal zone (66).
In other model systems, inactivation of the cadherin adhe-
sion complex seems to be associated with cell dedifferenti-
ation, invasion, and regional metastasis (67, 68), all processes
requiring cell motility. Based on these data, we focused our
attention on the adhesive properties of GN-11 cells and an-
alyzed the expression of N-cadherins in our experimental
model. Interestingly, we found out that the expression pat-
terns of stathmin and N-cadherins are inversely correlated:
overexpression of stathmin induces a down-regulation of
N-cadherin expression and the loss of the ability to form cell
aggregates by the hanging-drop technique, whereas down-
regulation of stathmin is accompanied by an increase in
N-cadherin protein expression and cell-cell adhesion. A cor-
relation between stathmin and cadherins has been previ-
ously highlighted by Balogh and co-workers (69), who
showed that cell-cell contacts, probably mediated by cad-
herins, may be important in the control of stathmin
expression.
Using transwell assay, we showed that spontaneous mi-
gratory activity of GN-11 cells is sensitive to stathmin con-
tent. Indeed, transfection of GN-11 cells with stathmin sense
construct significantly increases basal migration, whereas
down-regulation of stathmin expression by antisense con-
struct transfection inhibits such activity when compared
with control cells. These results are in accordance with those
of Jin and co-workers (61) demonstrating a role for stathmin
in the rostral migratory stream neuronal migration by ven-
tricular antisense oligonucleotide injection.
HGF/SFmotogenic activity has been demonstrated in sev-
eral cell lines, during embryogenesis, and in metastatic tis-
sues (for a review see Ref. 38). In the developing CNS,
HGF/SF and its receptor c-Met are involved in themigration
of cortical (70) and GnRH neurons (45). In addition, GN-11
cells have been previously shown to express c-Met and dis-
play chemotactic responsiveness to HGF/SF stimulation
(45). Because the level of c-Met expression is not affected by
stathmin content, the migratory activity of STMN, pIRES,
and STMN transfectants has been measured under the
exposure to HGF/SF. A chemotactic response to HGF/SF is
observed for all transfectants and the amplitude of the re-
sponse correlates to stathmin content. The activation of c-Met
receptor by HGF/SF leads to the recruitment, among others,
of the scaffolding protein Grb2, which activates Rac-1 (38).
On the other hand, the activation of Rac-1-dependent kinase
has been recently demonstrated to regulate stathmin activity
at the leading edge of migrating cells (71, 72). Therefore, a
challenging hypothesis that will deserve further investiga-
tion is the regulation of stathmin activity byRac-1-dependent
kinase in GN-11 cells in response to HGF/SF.
The temporal expression of stathmin protein by migrating
GnRHneurons is in accordancewith the in vitro findings that
we obtained using GN-11 cell line. In addition, once GnRH
neurons have reached their final hypothalamic destinations,
they no longer express stathmin and complete their differ-
entiation to become integral components of the hypothalam-
ic-pituitary-gonadal axis,which is essential for establishment
of reproductive competence. Whether down-regulation of
stathmin expression is a necessary step for GnRH neuronal
differentiation or, inversely, a consequence of the differen-
tiation program of the neuroendocrine cells, deserves further
investigations.
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